Highlights from Stanford Drug Discovery Symposium 2021
Cardiovasc Res
.
2021 Aug 29;117(10):e132-e134.
doi: 10.1093/cvr/cvab250.
Authors
Amanda J Chase
1
,
Sanjay V Malhotra
2
3
,
Mark Mercola
1
4
,
Kuldev Singh
5
,
Joseph C Wu
6
7
Affiliations
1
Stanford Cardiovascular Institute, Stanford, CA, USA.
2
Department of Cell, Development and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.
3
Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
4
Department of Medicine, Stanford University, Stanford CA.
5
Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USA.
6
Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
7
Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
PMID:
34417601
PMCID:
PMC8499776
DOI:
10.1093/cvr/cvab250
No abstract available
Keywords:
Drug discovery; COVID-19; Drug development; Translation; Vaccine.